Identification of a 76-year-old Patient with Compound Heterozygous Familial Hypercholesterolemia by Haplotype Analysis of the LDL Receptor Gene

Overview

Journal Klin Wochenschr

Specialty General Medicine

Date 1991 Nov 15

PMID 1685207

Authors

H J FISCHER

H Schuster

C Keller

G Wolfram

N Zollner

Affiliations

Soon will be listed here.

Abstract

In a large family with clinical characteristics of heterozygous familial hypercholesterolemia (FH) seven restriction fragment length polymorphisms (RFLP) were used to determine low-density-lipoprotein receptor (LDLR) gene haplotypes. Following the inheritance of the LDL receptor genes characterized by their seven RFLP haplotypes, two different alleles were found to cosegregate with elevated cholesterol levels within this family. In a 76-year-old man both alleles identified as defective were present, thus classifying this individual as heterozygous compound for FH. In five heterozygous family members one allele was associated with 38% higher cholesterol levels when compared to the other mutant allele in two heterozygous family members. Cosegregation of hypercholesterolemia with the apolipoprotein B (apoB) gene and apolipoprotein E (apoE) gene was excluded by genotyping all individuals for the apoB XbaI RFLP and apoE polymorphisms. These findings are consistent with variable phenotypic expression of the mutant LDLR gene alleles.

References

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

Botstein D, White R, Skolnick M, Davis R . Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet. 1980; 32(3):314-31. PMC: 1686077. View

Kotze M, Langenhoven E, Retief A, SEFTEL H, Henderson H, Weich H . Haplotypes identified by 10 DNA restriction fragment length polymorphisms at the human low density lipoprotein receptor gene locus. J Med Genet. 1989; 26(4):255-9. PMC: 1017299. DOI: 10.1136/jmg.26.4.255. View

Cuthbert J, East C, Bilheimer D, Lipsky P . Detection of familial hypercholesterolemia by assaying functional low-density-lipoprotein receptors on lymphocytes. N Engl J Med. 1986; 314(14):879-83. DOI: 10.1056/NEJM198604033141404. View

Goldstein J, Brown M . The LDL receptor and the regulation of cellular cholesterol metabolism. J Cell Sci Suppl. 1985; 3:131-7. DOI: 10.1242/jcs.1985.supplement_3.13. View

Hobbs H, Leitersdorf E, Leffert C, Cryer D, Brown M, Goldstein J . Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors. J Clin Invest. 1989; 84(2):656-64. PMC: 548929. DOI: 10.1172/JCI114212. View

Taylor R, Jeenah M, Seed M, Humphries S . Four DNA polymorphisms in the LDL receptor gene: their genetic relationship and use in the study of variation at the LDL receptor locus. J Med Genet. 1988; 25(10):653-9. PMC: 1051557. DOI: 10.1136/jmg.25.10.653. View

Davignon J, GREGG R, Sing C . Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988; 8(1):1-21. DOI: 10.1161/01.atv.8.1.1. View

Kunkel L, Smith K, Boyer S, Borgaonkar D, Wachtel S, MILLER O . Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A. 1977; 74(3):1245-9. PMC: 430660. DOI: 10.1073/pnas.74.3.1245. View

10.

Schuster H, Stiefenhofer B, Wolfram G, Keller C, Humphries S, Huber A . Four DNA polymorphisms in the LDL-receptor gene and their use in diagnosis of familial hypercholesterolemia. Hum Genet. 1989; 82(1):69-72. DOI: 10.1007/BF00288276. View

11.

Soria L, Ludwig E, Clarke H, Vega G, Grundy S, McCarthy B . Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A. 1989; 86(2):587-91. PMC: 286517. DOI: 10.1073/pnas.86.2.587. View

12.

Hixson J, Vernier D . Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990; 31(3):545-8. View

13.

Leitersdorf E, Chakravarti A, Hobbs H . Polymorphic DNA haplotypes at the LDL receptor locus. Am J Hum Genet. 1989; 44(3):409-21. PMC: 1715440. View

14.

Hobbs H, Leitersdorf E, Goldstein J, Brown M, Russell D . Multiple crm- mutations in familial hypercholesterolemia. Evidence for 13 alleles, including four deletions. J Clin Invest. 1988; 81(3):909-17. PMC: 442544. DOI: 10.1172/JCI113402. View

15.

Aalto-Setala K, Gylling H, Helve E, Kovanen P, Miettinen T, Turtola H . Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolemia. Hum Genet. 1989; 82(4):305-7. DOI: 10.1007/BF00273986. View

16.

Daga A, Mattioni T, BALESTRERI R, Coviello D, Corte G, Bertolini S . Use of three DNA polymorphisms of the LDL receptor gene in the diagnosis of familial hypercholesterolemia. Hum Genet. 1990; 84(5):412-6. DOI: 10.1007/BF00195811. View

17.

Hobbs H, Brown M, Russell D, Davignon J, Goldstein J . Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. N Engl J Med. 1987; 317(12):734-7. DOI: 10.1056/NEJM198709173171204. View

18.

Talmud P, Barni N, Kessling A, Carlsson P, Darnfors C, Bjursell G . Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidaemic individuals. Atherosclerosis. 1987; 67(1):81-9. DOI: 10.1016/0021-9150(87)90267-x. View

19.

Leitersdorf E, van der Westhuyzen D, Coetzee G, Hobbs H . Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners. J Clin Invest. 1989; 84(3):954-61. PMC: 329741. DOI: 10.1172/JCI114258. View

20.

Aalto-Setala K, Tikkanen M, Taskinen M, Nieminen M, HOLMBERG P, Kontula K . XbaI and c/g polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in Finland. Atherosclerosis. 1988; 74(1-2):47-54. DOI: 10.1016/0021-9150(88)90190-6. View